Nuvectra Corp Balance Sheet | Understand Stock

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 30, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jul 1, 2016	Q1 FY2016 As of Apr 1, 2016
Current assets:
Cash and cash equivalents
Trade accounts receivable, net of allowance for doubtful accounts of $641 and $691 in 2019 and 2018, respectively
Inventories
Prepaid expenses and other current assets
Current assets of discontinued operations
Total current assets
Property, plant and equipment, net
Intangible assets, net
Goodwill
Other long-term assets
Noncurrent assets of discontinued operations
Total assets
Current liabilities:
Accounts payable and other current liabilities
Accounts payable
Accrued liabilities
Other accrued compensation
Accrued bonuses
Deferred revenue
Accrued compensation
Short-term debt
Current liabilities of discontinued operations
Total current liabilities
Other long-term liabilities
Long-term debt, net
Total liabilities
Stockholders’ equity:
Common stock, $0.001 par value, 100,000,000 shares authorized; 17,885,297 and 17,689,928 shares issued and outstanding in 2019 and 2018, respectively
Additional paid-in capital
Accumulated other comprehensive gain
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments